316 related articles for article (PubMed ID: 33116404)
1. Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells.
Qorri B; Harless W; Szewczuk MR
Drug Des Devel Ther; 2020; 14():4149-4167. PubMed ID: 33116404
[TBL] [Abstract][Full Text] [Related]
2. A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
Gilmour AM; Abdulkhalek S; Cheng TS; Alghamdi F; Jayanth P; O'Shea LK; Geen O; Arvizu LA; Szewczuk MR
Cell Signal; 2013 Dec; 25(12):2587-603. PubMed ID: 23993964
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy.
Ali S; El-Rayes BF; Sarkar FH; Philip PA
Mol Cancer Ther; 2005 Dec; 4(12):1943-51. PubMed ID: 16373709
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effect and mechanism of cyclooxygenase-2 inhibitor through matrix metalloproteinase 14 pathway in PANC-1 cells.
Li S; Gu Z; Xiao Z; Zhou T; Li J; Sun K
Int J Clin Exp Pathol; 2015; 8(2):1737-42. PubMed ID: 25973062
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib suppresses fibroblast growth factor-2 expression in pancreatic ductal adenocarcinoma PANC-1 cells.
Li J; Luo M; Wang Y; Shang B; Dong L
Oncol Rep; 2016 Sep; 36(3):1345-52. PubMed ID: 27430377
[TBL] [Abstract][Full Text] [Related]
6. Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy.
Yang M; Wang L; Ni M; Neuber B; Wang S; Gong W; Sauer T; Schubert ML; Hückelhoven-Krauss A; Xia R; Ge J; Kleist C; Eckstein V; Sellner L; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2021; 12():670088. PubMed ID: 34122428
[TBL] [Abstract][Full Text] [Related]
7. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
[TBL] [Abstract][Full Text] [Related]
8. Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells.
Li N; Li H; Su F; Li J; Ma X; Gong P
Int J Clin Exp Pathol; 2015; 8(8):9010-20. PubMed ID: 26464643
[TBL] [Abstract][Full Text] [Related]
9. [The growth inhibitory effect of non-steroid anti-inflammatory drugs on ovarian cancer].
Wang HJ; Peng ZL; Liu XQ; Yang KX; Lou JY; Luo FM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):428-32. PubMed ID: 17593823
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis.
Haxho F; Neufeld RJ; Szewczuk MR
Oncotarget; 2016 Jun; 7(26):40860-40881. PubMed ID: 27029067
[TBL] [Abstract][Full Text] [Related]
11. [Effects of selective and non-selective cyclooxygenase-2 inhibitor on the growth of colon cancer cells].
Wang CH; Ouyang Q; Tang CW; Huang MH; Li X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):547-50. PubMed ID: 16909598
[TBL] [Abstract][Full Text] [Related]
12. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
[TBL] [Abstract][Full Text] [Related]
13. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
14. ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib.
Liu J; Wu J; Zhou L; Pan C; Zhou Y; Du W; Chen JM; Zhu X; Shen J; Chen S; Liu RY; Huang W
Oncotarget; 2015 Aug; 6(25):21341-52. PubMed ID: 26050198
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
Volpato M; Ingram N; Perry SL; Spencer J; Race AD; Marshall C; Hutchinson JM; Nicolaou A; Loadman PM; Coletta PL; Hull MA
Cancer Chemother Pharmacol; 2021 Feb; 87(2):173-184. PubMed ID: 33040178
[TBL] [Abstract][Full Text] [Related]
17. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.
Venkatesan P; Bhutia SK; Singh AK; Das SK; Dash R; Chaudhury K; Sarkar D; Fisher PB; Mandal M
Life Sci; 2012 Oct; 91(15-16):789-99. PubMed ID: 22922496
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib inhibits cell growth and modulates the expression of matrix metalloproteinases in human osteosarcoma MG-63 cell line.
Zhou X; Shi X; Ren K; Fan GT; Wu SJ; Zhao JN
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4087-97. PubMed ID: 26592832
[TBL] [Abstract][Full Text] [Related]
19. Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy against Breast Cancer Cell Models.
Bardaweel SK; Dahabiyeh LA; Akileh BM; Shalabi DD; AlHiary AK; Pawling J; Dennis JW; Rahman AMA
Anticancer Agents Med Chem; 2022; 22(8):1611-1621. PubMed ID: 34515014
[TBL] [Abstract][Full Text] [Related]
20. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.
Ma JX; Sun YL; Wang YQ; Wu HY; Jin J; Yu XF
Oncol Res; 2013; 20(8):359-68. PubMed ID: 23924856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
